| Literature DB >> 31972425 |
Ping Xin1, Xiaoyun Xu1, Chengjie Deng1, Shuang Liu1, Youzhi Wang2, Xuegang Zhou1, Hongxing Ma3, Donghua Wei1, Shiqin Sun4.
Abstract
The JAK/STAT signaling pathway is an universally expressed intracellular signal transduction pathway and involved in many crucial biological processes, including cell proliferation, differentiation, apoptosis, and immune regulation. It provides a direct mechanism for extracellular factors-regulated gene expression. Current researches on this pathway have been focusing on the inflammatory and neoplastic diseases and related drug. The mechanism of JAK/STAT signaling is relatively simple. However, the biological consequences of the pathway are complicated due to its crosstalk with other signaling pathways. In addition, there is increasing evidence indicates that the persistent activation of JAK/STAT signaling pathway is closely related to many immune and inflammatory diseases, yet the specific mechanism remains unclear. Therefore, it is necessary to study the detailed mechanisms of JAK/STAT signaling in disease formation to provide critical reference for clinical treatments of the diseases. In this review, we focus on the structure of JAKs and STATs, the JAK/STAT signaling pathway and its negative regulators, the associated diseases, and the JAK inhibitors for the clinical therapy.Entities:
Keywords: JAK/STAT pathway and diseases; JAK/STAT signaling pathway; JAKs inhibitors and diseases; Negative regulators
Year: 2020 PMID: 31972425 DOI: 10.1016/j.intimp.2020.106210
Source DB: PubMed Journal: Int Immunopharmacol ISSN: 1567-5769 Impact factor: 4.932